Tech Stocks emergin...
Health Care: Drugs
Athersys Inc. (ATHX: OTC)
$1.71 0.09 | 5.56%
06/18/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 8.71M | 10.34M | 8.94M | 2.16M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 8.71M | 10.34M | 8.94M | 2.16M |
| Selling, General, and Administrative Expenses | 3.57M | 4.92M | 5.39M | 5.62M |
| Research & Development | 19.64M | 18.93M | 14.78M | 11.92M |
| Operating Income before D & A (EBITDA) | -14.50M | -13.50M | -11.23M | -15.38M |
| Depreciation & Amortization | 331.00K | 336.00K | 509.00K | 538.00K |
| Interest Income | 34.00K | 85.00K | 203.00K | 375.00K |
| Other Income - Net | 50.00K | -51.00K | -69.00K | -126.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -14.75M | -13.80M | -11.60M | -15.67M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -14.75M | -13.80M | -11.60M | -15.67M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -14.74M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -14.74M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -14.74M | -13.75M | -11.38M | -15.37M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-14.74M | 0.00 | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -14.74M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -0.45 | -0.59 | -0.60 | -0.81 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.45 | -0.59 | -0.60 | -0.81 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.45 | -0.59 | -0.60 | -0.81 |
| Basic Normalized Net Income/Share | -0.45 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.45 | -0.59 | -0.60 | -0.81 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.45 | -0.59 | -0.60 | -0.81 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.45 | -0.59 | -0.60 | -0.81 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.45 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ATHX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- UserAlfa
- Contributor9 Health Care Stocks With 1...
- Contributor10 Pharma Stocks With 100% ...
- Contributor10 Biotech Stocks Expected ...
- UserFuture Speculation
- User©SUPRATRADE HOT STOCKS (...
- UserBesV Portfolio 1
- Userdawnf Portfolio 1
Latest ATHX Headlines from TheStreet
- Athersys To Host First Quarter 2013 Financial Results Call 04.18.13 | 10:04 am
- Athersys Announces Authorization Of Stem Cell Clinical Trial For Stroke In The United Kingdom 04.17.13 | 01:04 pm
- Athersys To Present At Regen Med Investor Day 2013 In New York 04.11.13 | 08:04 am
- Publications Demonstrate Relevance Of MultiStem(R) For Autoimmune Disease, Transplantation And Vascular Disease 04.10.13 | 11:04 am
- Athersys Reports Fourth Quarter And 2012 Annual Results 03.12.13 | 04:03 pm
- Athersys To Host Fourth Quarter And Year-End 2012 Financial Results Call 02.25.13 | 04:02 pm
- Athersys Announces Adjournment Of Special Meeting Date 02.21.13 | 10:02 am
- Athersys To Present At New York Stem Cell Summit '13 02.13.13 | 12:02 pm
- Athersys To Present At BIO CEO & Investor Conference 02.11.13 | 10:02 am
- 5 Biotech Stocks Under $10 Moving Higher 01.30.13 | 08:01 am
Press Releases for ATHX
- Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online - PR Newswire 01.24.11 | 12:01 pm
- RTI Biologics And Athersys Announce Collaboration In The Orthopedic Market - Business Wire 09.13.10 | 07:09 am
Partner Headlines for ATHX
- A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships - Seeking Alpha 03.18.13 | 09:03 am
- Athersys Prices 19.8M Shares at $1.01 - Benzinga 10.26.12 | 09:10 am
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Microcap Movers for Friday December 2 , 2011 - Benzinga 12.02.11 | 05:12 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 09.23.11 | 09:09 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.26.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.12.11 | 09:08 am
